ProShares Ultra CRCL ETF is a leveraged exchange-traded fund, not an operating company. It seeks twice the daily price performance of Circle Internet Group, the issuer of the USDC stablecoin, using total return swaps. On Monday, the fund traded at $7.79, down $1.38 or 15.05% from Friday's close of $9.17, in a session that opened with a gap lower and never recovered. The direction was unambiguously negative, and the move was driven by sector-wide pressure rather than any fund-specific announcement.
Bitcoin spent the weekend under heavy liquidation pressure, touching roughly $62,000, its weakest level since the summer, before recovering toward $64,300 during Monday's session. The coin has now fallen for six consecutive weeks and is down about 17% in November. US spot bitcoin ETFs shed more than $1 billion in the week through November 13, extending an outflow streak, while stablecoin balances have contracted by roughly $20 billion over the past month, a direct signal of shrinking crypto liquidity. Crypto equities absorbed steeper losses than the coin itself, a familiar pattern when traders reduce leveraged exposure in vehicles that only trade during Wall Street hours.
The fund's mandate explains most of the magnitude. Circle shares fell about 7.2% intraday, and the 2x daily reset translated that into a decline of roughly 15%. Because the fund rebalances daily, sustained volatility erodes net asset value relative to a simple doubling of the underlying stock over longer periods. With Circle down more than 70% from its September highs, that compounding effect has been persistent. Net assets sit below $100 million, so order flow in a small, single-stock leveraged product can widen spreads and exaggerate intraday swings.
No new Circle filing or disclosure drove Monday's move, but the underlying business has its own soft spots. Third-quarter results on November 4 beat estimates on revenue of $864.9 million and earnings of $0.84 per share, yet $182 million of that revenue came from an ARC token presale. USDC circulation was flat year over year at $73.9 billion and had slipped to $70.7 billion by early November. Management guided to lower fourth-quarter margins as it absorbs the cost of an expanded Binance distribution deal, and several analysts cut price targets after the print.
Markets also carried a broader defensive tone. The 10-year Treasury yield held near 5.13%, and futures priced a December Fed rate increase at better than 90%. Nvidia's leadership uncertainty and its earnings report on Tuesday, alongside Anthropic's large IPO later this week, kept investors reducing high-beta exposure. MSCI's decision to remove Strategy from its indexes at month-end added to the chill across crypto-linked equities.
The fund gapped down at the open and printed an intraday low of $7.72, a new 52-week low and roughly 73% below its early-September close of $29.30. Volume was unremarkable rather than panicked: about 222,000 shares had changed hands by early afternoon, tracking close to a recent daily average near 410,000 shares. The move exceeded the broader market by a wide margin, and losses were concentrated in crypto-linked names rather than the indexes. Technically, the ETF trades well below its 20-, 50- and 200-day moving averages, and Monday's gap lower broke beneath the November 13 intraday low of $8.67.
The score runs from 0, meaning no meaningful news and a move that is routine for the stock, to 100, meaning transformative news and an extreme, rare price move. This event earns a 20 out of 100.
Verified news was macro and sector-level rather than company-specific: a bitcoin pullback, ETF outflows and tightening rate expectations. That is meaningful context for a crypto proxy, but not a fundamental shock to this fund. The price move, while large in absolute terms, was only about 1.9 times the fund's typical daily move of roughly 7.8%, and 8 of the last 60 sessions produced moves of 15% or more. Both components are therefore modest, which keeps the score low.
Attention stays on bitcoin's ability to defend the $64,000 area and the weekend low near $62,200; a decisive break would pressure crypto equities further, while stabilization would likely ease the selling. Weekly spot ETF flow figures, Fed Chair Kevin Warsh's remarks on the rate path and Tuesday's retail sales data are the near-term macro inputs. Circle's fourth-quarter results, expected in February, will be scrutinized for USDC circulation and reserve margin trends, and the company is also searching for a successor to its departing chief financial officer. The GENIUS Act's stablecoin framework takes effect in January 2027, a potential structural tailwind. The core risk remains simple: daily-reset leverage in a volatile single name cuts both ways.
Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions earn a place in its curated Trending AI Robots section. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, so the page offers a practical way to compare live approaches side by side during a fast-moving tape. For traders navigating volatility like today's, reviewing the current leaders is a sensible next step.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CRCA saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned negative. In 22 of the 24 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CRCA turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CRCA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCA advanced for three days, in 50 of 57 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CRCA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.